Breathing in tiny air pollution particles could increase the risk of Parkinson's disease, scientists have ... This form of the disorder is called juvenile Parkinsonism and is often associated ...

WEST CHESTER, PA — Pathways Neuro Pharma Inc. has announced a significant pivot in its development pipeline, prioritizing rare pediatric neurological disorders, with Juvenile Parkinson’s Disease (JPD) ...

Expanding the Pipeline Beyond Juvenile Parkinson’s Disease While Juvenile Parkinson’s Disease is the initial focus, Pathways Neuro Pharma is exploring additional indications where its gene ...

Professor Karlo Malaga leads research focusing on pinpointing specific areas in the subthalamic region where deep brain ...

From there, they estimated how common Parkinson’s disease is based on a slew of factors, including a person’s age and sex, from 2022 to 2050. The researchers estimated that the number of ...

In October that year, the 36-year-old was diagnosed with juvenile Parkinson’s disease, a rare, intractable disease that robs patients of the ability to move. When she returned to her workplace ...

There is still no cure for Parkinson’s disease, but the U.S. Food and Drug Administration (FDA) approved a new deep brain stimulator that could benefit patients with the motor condition.

In 1997, the World Health Organization declared April 11 as World Parkinson's Day, celebrating the birth of James Parkinson, a British neurologist, who in 1817 published a book where, for the ...

(MENAFN- EIN Presswire) Pathways Neuro Pharma shifts focus to rare pediatric diseases, advancing a groundbreaking non-agonist gene therapy for Juvenile Parkinson's Disease. Children diagnosed with ...